Methods Development
Esco Aster Provides CMC Manufacturing Support For Shine On Biomedical’s HLA G Targeted Exosome Program
Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedica...
December 17, 2025 | News
Thermo Fisher Scientific Advances Microbial Bioprocessing With Chemically Defined Media For Confident Plasmid DNA And Protein Scale Up
New formulations simplify microbial bioprocessing, helping innovators scale plasmid DNA and protein production with confidence Thermo Fisher Scientific In...
December 16, 2025 | News
Bora Pharmaceuticals Forms Strategic Alliance with Corealis Pharma to Streamline Drug Development
Partnership creates simplified pathway from early development to commercial launch Bora Pharmaceuticals Co., Ltd. ("Bora", TWSE: 6472), a global leader ...
December 10, 2025 | News
AGC Biologics Strengthens Global Cell Line Capabilities With ATUM Partnership and Leap In Technology
New offering provides drug developers with flexible and powerful cell line development options for monoclonal antibodies, multi-specific and complex mole...
December 04, 2025 | News
BioDlink Drives Global Biologics Innovation with World’s First Approved EGFR-Targeted ADC
Recognized as Biologics CDMO of the Year, BioDlink shares insights into the world's first approved EGFR-targeted ADC for recurrent/metastatic nasopharyng...
December 01, 2025 | News
Piramal Pharma Solutions Achieves Full Compliance With Global Nitrosamine Standards
Piramal Pharma Solutions implemented a robust action plan to address evolving regulatory requirements pertaining to nitrosamine impur...
November 28, 2025 | News
China Marks a Landmark Moment as BioDlink and Lepu Biopharma Launch the World’s First EGFR Targeting ADC
Celebrating a Shared Milestone: BioDlink and Lepu Biopharma celebrated the launch of MEIYOUHENG®, the world's first EGFR-Targeting ADC, and their par...
November 24, 2025 | News
Evonik and InVitria Partner to Expand Global Supply of Animal Component-Free Recombinant HSA
Expanded supply of animal component-free human serum albumin for advanced therapies and next-generation biopharmaceutical processes Safer, more consiste...
November 18, 2025 | News
Genezen Partners with Humane Genomics to Manufacture Novel Oncolytic Therapy for Paediatric Liver Cancer
Genezen, a leading viral vector Contract Development and Manufacturing Organization (CDMO), and Humane Genomics, a biotechnology company developing oncolyt...
November 13, 2025 | News
Mölnlycke Establishes First Wound Care Manufacturing Site in China to Strengthen Local Production and Supply Chain Resilience
Mölnlycke® Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden, is celebrating the commencement of its new wound car...
November 06, 2025 | News
Bio-Techne and Nucleai Demonstrate Predictive Power of Spatial Biomarkers in Melanoma
Clinical trial data demonstrates how Bio-Techne's spatial biology technology and Nucleai's AI-powered multimodal platforms can identify predictive biomar...
November 05, 2025 | News
Samsung Epis Holdings Established as New Biotechnology Investment Holding Company Following Spin-Off from Samsung Biologics
Samsung Epis Holdings Co., Ltd.announced its establishment as a new investment holding company, following the spin-off of Samsung Bioepis Co., Ltd. from Sa...
November 04, 2025 | News
Lonza to Acquire Redberry SAS, Advancing Rapid Microbiology Testing with Solid-Phase Cytometry Technology
Lonza, one of the world’s largest contract development and manufacturing organizations (CDMOs), announced that it has signed an agreement to acquire ...
October 31, 2025 | News
NEOM and WuXi AppTec Partner to Build World-Class Pharmaceutical R&D and Manufacturing Capabilities in Saudi Arabia
NEOM, the sustainable region taking shape in northwest Saudi Arabia, has signed a strategic memorandum of understanding (MoU) with WuXi AppTec, a leading g...
October 28, 2025 | News
Most Read
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
